Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Z. Steven Pavletic"'
Autor:
Lynette M. Smith, Z. Steven Pavletic, Warren G. Sanger, John D. Dickinson, Shantaram S. Joshi, Philip J. Bierman, Guimei Zhou, Peter Townley, James C. Lynch
Publikováno v:
British Journal of Haematology. 128:460-471
Chromosome abnormalities influence prognosis and tumour progression in B-cell Chronic Lymphocytic Leukaemia (CLL). This study sought to determine whether these different disease subgroups were associated with unique gene expression patterns. Thirty-f
Increased Apoptosis in B-chronic Lymphocytic Leukemia Cells as a Result of Cyclin D3 Down Regulation
Publikováno v:
Leukemia & Lymphoma. 43:1827-1835
B-cell chronic lymphocytic leukemia (CLL) is a clonal B cell malignancy of morphologically mature, functionally immature B cells. B-cell CLL cells are known to be resistant to killing by anticancer and other agents. This resistance is associated with
Autor:
Anne Kessinger, Stefano R. Tarantolo, Z. Steven Pavletic, Michael R. Bishop, Julie M. Vose, Susan Kruse, James C. Lynch, James O. Armitage, Robert B. Geller, Mary E. Morris, Philip J. Bierman, Suzanne P. Dix
Publikováno v:
Blood. 96:80-85
Blood stem cell transplantation (BSCT) results in rapid hematopoietic recovery in both the allogeneic and autologous transplant settings. Because of the large numbers of progenitor cells in mobilized blood, the administration of growth factors after
Autor:
Julie M. Vose, James O. Armitage, Elizabeth I. Ruby, Anne Kessinger, Stefano R. Tarantolo, William D. Haire, Z. Steven Pavletic, Michael R. Bishop, L. C. Stephens, Philip J. Bierman, Elizabeth C. Reed
Publikováno v:
Biology of Blood and Marrow Transplantation. 4(3):142-150
Many of the complications of high-dose therapy with hematopoietic stem cells are caused by or lead to the multiple-organ dysfunction syndrome (MODS). In hematopoietic stem cell transplantation (HSCT), acquired antithrombin III (ATIII) deficiency is i
Autor:
James O. Armitage, Z. Steven Pavletic
Publikováno v:
The Oncologist. 1:159-168
The number of allogeneic and autologous bone marrow transplants continues to grow worldwide. Bone marrow transplantation (BMT) has become standard therapy for many patients with leukemia, lymphoma, multiple myeloma and testicular cancer. Encouraging
Autor:
Z. Steven Pavletic, Anne Kessinger, James C. Lynch, Stefano R. Tarantolo, Diane Zacharias, Mary E. Morris, Michael R. Bishop, James O. Armitage
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(11)
PURPOSE: Donor leukocyte infusion (DLI) effectively treats relapse after allogeneic stem-cell transplantation (alloSCT), but the response may require several months and may be associated with significant toxicity. Filgrastim has also been observed to
Autor:
Z. Steven Pavletic
Publikováno v:
Annals of Internal Medicine. 127:572